Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells

Coral García-Fernández, Alba López-Fernández, Salvador Borrós, Martí Lecina, Joaquim Vives

Research output: Indexed journal article Reviewpeer-review

16 Citations (Scopus)


Production of sufficient numbers of multipotent Mesenchymal Stromal Cells is a great challenge that the industry must address to meet the increasing demand for clinical size product batches. This can be understood as an opportunity to exploit existing bioprocessing technologies already tested successfully in the production of vaccines and biologicals. Herein we analyse the transition from traditional manual cell expansion 2D methodologies to scalable and automated platforms with the capacity to yield billions of cells per batch in a robust, reproducible and cost-effective manner in compliance with current Good Manufacturing Practices. This review gives special relevance to the key features of multiple manufacturing platforms, particularly those using microcarriers to support cell expansion and single-use bioreactors.

Original languageEnglish
Article number107601
JournalBiochemical Engineering Journal
Publication statusPublished - 15 Jul 2020


  • Expansion culture platforms
  • Good manufacturing practices
  • Logistics
  • Multipotent mesenchymal stromal cell
  • Scale up
  • Single-use bioreactors


Dive into the research topics of 'Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells'. Together they form a unique fingerprint.

Cite this